From the Department of Ophthalmology (van der Geest, Siemerink, Mura, Mourits, Lapid-Gortzak), University of Amsterdam, Academic Medical Center, and Zonnestraal Eye Hospital (Mura, Mourits, Lapid-Gortzak), Amsterdam, and Retina Total Eye Care (Lapid-Gortzak), Driebergen, the Netherlands.
From the Department of Ophthalmology (van der Geest, Siemerink, Mura, Mourits, Lapid-Gortzak), University of Amsterdam, Academic Medical Center, and Zonnestraal Eye Hospital (Mura, Mourits, Lapid-Gortzak), Amsterdam, and Retina Total Eye Care (Lapid-Gortzak), Driebergen, the Netherlands.
J Cataract Refract Surg. 2016 Jun;42(6):840-5. doi: 10.1016/j.jcrs.2016.03.034.
To evaluate the refractive accuracy of intraocular lens (IOL) power calculation after phacovitrectomy.
Eye Hospital Zonnestraal and Department of Ophthalmology Academic Medical Center, Amsterdam, the Netherlands.
Retrospective comparative case series.
Refraction results 1 month after phacovitrectomy or phacoemulsification were compared with predicted refractions calculated using the IOLMaster 500 and the Haigis formula. Indications for vitrectomy were macular pucker, macular hole, vitreous floaters, vitreous hemorrhage, and vitreomacular traction. Enrolled eyes had an axial length (AL) between 20.13 mm and 29.43 mm.
The phacovitrectomy group comprised 133 eyes (133 patients) and the phacoemulsification group, 132 eyes (132 patients). The refractive outcomes after phacovitrectomy (-0.06 diopter [D] ± 0.50 [SD]) and phacoemulsification (-0.08 ± 0.47 D) were comparable (P = .74). The final postoperative refraction was within ±1.00 D of the preoperative refractive target in 94.9% and 94.6% of phacovitrectomy cases and phacoemulsification cases, respectively. Subgroup analysis found no increased risk for refractive surprises after gas tamponade or in eyes with an AL of 26.00 mm or greater.
Standard IOL power calculation used in regular phacoemulsification surgery was accurate in phacovitrectomy procedures in eyes with a wide range of AL and a wide range of vitrectomy indications. No tendency toward a myopic shift was found.
Dr. Lapid-Gortzak is a clinical investigator for, speaker for, and consultant to Alcon Laboratories, Inc., Hanita Lenses, a speaker for Santen Pharmaceutical Co., and a consultant to Sanoculis and Orca Surgical. None of the authors has a financial or proprietary interest in any material or method mentioned.
评估白内障超声乳化吸除术后人工晶状体(IOL)屈光力计算的准确性。
荷兰阿姆斯特丹 Zonnestraal 眼科医院和阿姆斯特丹学术医学中心眼科。
回顾性比较病例系列。
将白内障超声乳化吸除术后或白内障超声乳化吸除术后 1 个月的屈光结果与使用 IOLMaster 500 和 Haigis 公式计算的预测屈光进行比较。玻璃体切割术的适应证包括黄斑前膜、黄斑裂孔、玻璃体混浊、玻璃体积血和玻璃体黄斑牵引。纳入的眼轴长度(AL)为 20.13-29.43mm。
白内障超声乳化吸除术组包括 133 只眼(133 例患者),白内障超声乳化吸除术组包括 132 只眼(132 例患者)。白内障超声乳化吸除术(-0.06 屈光度[D]±0.50[SD])和白内障超声乳化吸除术(-0.08±0.47 D)的屈光结果相当(P=0.74)。分别有 94.9%和 94.6%的白内障超声乳化吸除术病例和白内障超声乳化吸除术病例的最终术后屈光在±1.00 D 以内与术前屈光目标相符。亚组分析发现,在使用气体填充的情况下或在眼轴长度为 26.00mm 或更大的情况下,没有出现屈光意外的风险增加。
在 AL 范围广泛和玻璃体切割术适应证广泛的白内障超声乳化吸除术中,标准的 IOL 屈光力计算在常规白内障超声乳化吸除术中是准确的。未发现近视漂移的趋势。
Lapid-Gortzak 博士是 Alcon Laboratories,Inc.、Hanita Lenses 的临床研究者、演讲者和顾问,是 Santen Pharmaceutical Co. 的演讲者,是 Sanoculis 和 Orca Surgical 的顾问。作者均无任何材料或方法的财务或所有权利益。